Press Inquiry Form
If you are a journalist, editor, or media representative interested in covering AIMA and our innovations, please fill out the form below. We will get back to you as soon as possible.
Featured articles
Explore key blood parameters and their diagnostic value, enhanced by AIMA, the first patented AI platform for precise, early blood analysis.
Powerful tool for insurance companies, enabling significant cost reductions through early diagnostics, accurate risk assessment, fraud prevention, and process optimization.
Explore RDW's role in diagnosing anemias and systemic diseases with clinical significance, enhanced by AI like Aima for precision.
Modern medicine is making a significant leap forward with the integration of advanced technologies such as artificial intelligence (AI) in blood analysis.
Diagnostic errors in blood analysis may lead to misdiagnosis, treatment delays, and exacerbated chronic conditions. This article analyzes pre-analytical and interpretive errors, their clinical impact, and the role of AI in enhancing precision and mitigating risks.
Unveiling flaws in blood diagnostics, this piece explores AI, automation, and portable tech as keys to sharper, faster, and fairer testing.
This in-depth analysis explores the CBC, a vital diagnostic tool, detailing its key parameters, reference ranges, and clinical insights for healthcare professionals.
Сritical parameter derived from the Complete Blood Count (CBC), representing the concentration of hemoglobin within the erythrocyte mass.
Blood analysis remains a cornerstone of clinical medicine, facilitating the diagnosis of hematological, infectious, and systemic diseases.